Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Pfizer beats out Novo with $10B agreement to buy Metsera
After a chaotic bidding clash that only burst out into public view nine days ago, Pfizer has prevailed in its pursuit of obesity biotech Metsera.
Eric Sagonowsky
Nov 8, 2025 8:11am
Axsome adds AZ asset through Avenue subsidiary acquisition
Nov 6, 2025 10:50am
UroGen hands CTLA-4 drug back to Agenus after mulling ph. 1 data
Nov 6, 2025 10:00am
Registrar snaps up CMC Medical Devices to expand offerings
Nov 6, 2025 8:35am
Dynavax pays Vaxart $30M for oral COVID-19 vaccine program
Nov 6, 2025 5:50am
Judge denies Pfizer’s bid to block Novo’s offer for Metsera
Nov 5, 2025 5:23pm
